V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005458 | 320003777 | 1.7 | 82 | Palliative (P) | 2013-04-21 | 2013-07-20 | Bevacizumab+Carbo+Gemcitabine | N | N | 320019114 | RMS 2005 TRIAL |
| 320005459 | 320003777 | 1.81 | 83.9 | Palliative (P) | 2016-09-14 | 2016-10-19 | Carboplatin + Etoposide IV 3 day | N | N | 320019114 | IMATINIB |
| 320005460 | 320003778 | null | 68.7 | Palliative (P) | null | 2015-05-14 | Trifluridine + Tipiracil | N | N | 320019168 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320005461 | 320003779 | 1.67 | 67.5 | Disease modification (D) | 2015-06-24 | 2015-06-28 | CARBOPLATIN + ETOPOSIDE | N | N | 320019172 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 320005462 | 320005727 | 1.5 | 63.65 | Curative (C) | 2017-05-03 | 2017-05-03 | ICON8B TRIAL | 2 | 2 | 320019172 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005463 | 320003780 | 1.56 | null | Palliative (P) | 2017-12-16 | 2018-01-19 | ICON8 TRIAL | N | N | 320019184 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005464 | 320003780 | 1.79 | 72.8 | Palliative (P) | 2015-11-16 | 2015-11-16 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 320019184 | CARBOPLATIN + ETOPOSIDE |
| 320005465 | 320006661 | 1.75 | 65.8 | Disease modification (D) | null | 2015-09-02 | FLUOROURACIL + MITOMYCIN + RT | N | N | 320019210 | IMATINIB |
| 320005466 | 320003781 | 1.96 | 64.1 | Palliative (P) | 2015-12-28 | 2016-02-04 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 320019211 | CETUXIMAB + RT |
| 320005467 | 320003782 | 1.61 | 65.5 | Palliative (P) | 2015-05-22 | 2015-06-07 | CNS LGG 2004 03 vinc weekly+ carbo | null | null | 320019211 | CAPECITABINE |
| 320005468 | 320007101 | 1.7 | 50.6 | Palliative (P) | 2015-03-08 | 2015-03-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | Y | 320019230 | CISPLATIN + ETOPOSIDE |
| 320005469 | 320003786 | 1.62 | 55.3 | Palliative (P) | 2017-02-22 | 2017-03-09 | Paclitaxel albumin (Abraxane) 21day | 02 | N | 320019266 | CISPLATIN + PACLITAXEL |
| 320005470 | 320003789 | 1.63 | 75 | Curative (C) | 2015-09-17 | 2015-10-16 | ICON8B TRIAL | 02 | N | 320019274 | CARBOPLATIN + ETOPOSIDE |
| 320005471 | 320003789 | 1.7 | 65.4 | Curative (C) | 2018-05-03 | 2018-05-17 | Olaparib | N | Y | 320019274 | CARBOPLATIN + CETUXIMAB + FU |
| 320005472 | 320003789 | 1.6 | 78.7 | Palliative (P) | 2014-12-16 | 2014-12-17 | Trifluridine + Tipiracil | N | N | 320019274 | IVA |
| 320005473 | 320003791 | 1.7 | 71.4 | null | 2015-03-01 | 2015-07-14 | Docetaxel 75mg/m2 (21 day) | N | N | 320019296 | CETUXIMAB + CISPLATIN + FU |
| 320005474 | 320003791 | 1.59 | 72.8 | Palliative (P) | 2019-07-11 | 2019-07-11 | BEVACIZUMAB + CARBO | 02 | N | 320019296 | IRINOTECAN + MDG + PANITUMUMAB |
| 320005475 | 320003792 | 1.78 | 57.9 | Palliative (P) | 2014-06-13 | 2014-07-25 | STS Rhabdo RMS 2005 2nd Topo Carbo | N | N | 320019304 | TOPOTECAN |
| 320005477 | 320006667 | 1.81 | 85 | Adjuvant (A) | 2013-08-08 | 2013-08-08 | IVA | 02 | N | 320019348 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005478 | 320006667 | 1.75 | 73.9 | Palliative (P) | 2014-09-05 | 2014-09-14 | CARBOPLATIN + RT | Y | null | 320019348 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320005479 | 320003798 | 1.64 | 63 | Palliative (P) | 2013-05-10 | 2014-01-29 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | Y | 320019379 | CARBO + FLUOROURACIL |
| 320005480 | 320003799 | 1.72 | 87.15 | Palliative (P) | 2018-02-17 | 2018-03-02 | GEMCITABINE | 02 | N | 320019389 | CETUXIMAB + CISPLATIN + FU |
| 320005481 | 320003800 | 1.77 | null | Palliative (P) | 2013-04-21 | 2013-09-26 | Cetuximab + Radiotherapy Maint | 02 | N | 320019389 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005482 | 320003801 | 1.68 | 63.3 | Palliative (P) | 2015-06-12 | 2015-06-12 | Cisplatin+Gemcitabine (gallbladder) | N | N | 320019440 | VEMURAFENIB |
| 320005483 | 320003803 | 1.71 | 64.7 | Palliative (P) | 2016-07-31 | 2016-08-14 | VAI (Ifos 3g/m2) | N | N | 320019448 | EMA |
| 320005484 | 320003805 | null | 60 | Palliative (P) | 2017-04-19 | 2017-05-18 | Irinotecan + Modified De Gramont | N | N | 320019453 | DOCETAXEL |
| 320005485 | 320003807 | 1.72 | null | Disease modification (D) | 2016-06-25 | 2016-07-05 | Carboplatin + Etoposide iv&po | N | N | 320019453 | POUT TRIAL |
| 320005486 | 320006669 | null | 19.3 | Palliative (P) | 2015-08-15 | 2015-08-16 | ICON8B TRIAL | 02 | N | 320019459 | CISPLATIN + VINORELBINE |
| 320005487 | 320005743 | null | 70.4 | Palliative (P) | 2014-02-24 | 2014-03-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320019466 | CAV |
| 320005488 | 320005744 | 1.73 | 54 | Curative (C) | 2017-10-27 | 2017-12-14 | DOXORUBICIN | N | N | 320019466 | CARBOPLATIN + RT |
| 320005489 | 320003814 | 1.7 | 78 | Curative (C) | 2013-09-26 | 2013-10-09 | CAPECITABINE + OXALIPLATIN | 02 | N | 320019513 | CARBOPLATIN + GEMCITABINE + PACLITAXEL |
| 320005490 | 320005746 | 1.71 | 64 | Palliative (P) | 2015-04-21 | 2015-05-21 | Temozolomide + RT | N | N | 320019541 | CETUXIMAB + CISPLATIN + FU |
| 320005491 | 320003817 | 1.75 | 58.7 | Palliative (P) | 2017-02-28 | 2017-03-30 | CARBOPLATIN + RT | N | N | 320019567 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005492 | 320003817 | 1.76 | 105.3 | Not known (9) | 2015-03-14 | 2015-05-01 | EOX | null | null | 320019567 | CETUXIMAB + RT |
| 320005493 | 320003819 | null | 66 | Adjuvant (A) | 2013-09-22 | 2013-09-23 | CETUXIMAB + RT | 02 | N | 320019614 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 320005494 | 320003820 | 1.8 | 97 | Adjuvant (A) | 2014-05-20 | 2014-05-20 | Mitomycin Intravesical | 02 | Y | 320019647 | BCG |
| 320005495 | 320003821 | 1.55 | 63 | Curative (C) | 2014-04-25 | 2014-07-27 | ICON8B TRIAL | N | N | 320019652 | POUT TRIAL |
| 320005496 | 320003822 | 1.64 | 104.7 | Neo-adjuvant (N) | 2013-08-31 | 2013-09-13 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 320019676 | RMS 2005 TRIAL |
| 320005497 | 320003823 | 1.55 | null | Palliative (P) | 2013-01-10 | 2014-11-17 | PAC-PLAT | N | N | 320019677 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005498 | 320003824 | 1.66 | 53.5 | Palliative (P) | 2013-10-17 | 2013-11-07 | MVAC | N | N | 320019692 | CISPLATIN + GEMCITABINE |
| 320005499 | 320005750 | 1.86 | null | Adjuvant (A) | 2015-05-09 | 2015-06-01 | Carboplatin + Etoposide IV 3 day | 02 | Y | 320019705 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005500 | 320003825 | 1.62 | 64.6 | Adjuvant (A) | 2013-08-13 | 2013-08-29 | Cisplatin + Paclitaxel | N | N | 320019712 | PEMBROLIZUMAB |
| 320005503 | 320003827 | 1.66 | null | Palliative (P) | 2017-12-25 | 2018-01-01 | BENDAMUSTINE + RITUXIMAB | N | N | 320019736 | CISPLATIN + ETOPOSIDE |
| 320005506 | 320003829 | 1.78 | 121.6 | Palliative (P) | 2015-07-23 | 2015-08-09 | IMATINIB | null | null | 320019912 | DOCETAXEL |
| 320005508 | 320003831 | 1.8 | null | Neo-adjuvant (N) | 2013-11-24 | 2014-02-15 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | null | 320019920 | IMATINIB |
| 320005509 | 320005755 | 1.87 | null | Palliative (P) | null | 2015-09-20 | IVA | null | null | 320019929 | CAPECITABINE + CARBOPLATIN |
| 320005510 | 320003833 | 1.8 | 93.1 | Palliative (P) | 2014-06-27 | 2014-07-09 | Cyclophosphamide PO +Vinorelbine IV | N | null | 320019949 | IVA |
| 320005511 | 320003834 | null | 57.1 | Palliative (P) | 2014-02-15 | 2014-02-15 | CNS LGG 2004 03 vinc weekly+ carbo | Y | null | 320019969 | ICON TRIAL |
| 320005514 | 320003839 | 1.77 | 64.6 | Palliative (P) | 2015-07-23 | 2015-11-16 | Carbo F | N | N | 320020001 | DOXORUBICIN + IFOSFAMIDE |
| 320005515 | 320003839 | 1.61 | 64.2 | Palliative (P) | 2013-09-03 | 2014-05-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320020001 | CARBOPLATIN + ETOPOSIDE |